Ampersand Capital Partners Makes Growth Investment in VIVEbiotech
December 4, 2024
Ampersand Capital Partners has made a growth equity investment in VIVEbiotech to support expansion of the company’s lentiviral vector development and GMP manufacturing capabilities in San Sebastián, Gipuzkoa, Spain. The investment will fund capacity growth and execution of VIVEbiotech’s pipeline of customer projects for cell and gene therapy developers, and industry veteran Dr. Stefan Beyer has been named Chairman.
- Buyers
- Ampersand Capital Partners
- Targets
- VIVEbiotech
- Industry
- Biotechnology
- Location
- Gipuzkoa, Spain
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.